Patents by Inventor Vanessa Xanthakis

Vanessa Xanthakis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10996231
    Abstract: The present disclosure provides the use of two very long chain ceramides for determining the risk of cardiovascular disease.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: May 4, 2021
    Assignees: Washington University, Trustees of Boston University
    Inventors: Jean E. Schaffer, Daniel S. Ory, Linda Peterson, Vasan S. Ramachandran, Vanessa Xanthakis
  • Publication number: 20190295727
    Abstract: A method and system for assessing a patient's heart health and communication that assessment to the patient in an understandable format. Various personal data and information regarding personal risk factors are used to calculate a CVH score. The CVH score, patient's actual age, and various predetermined functional parameters specific to the patient's race and sex are used to calculate a vascular age of the patient. The vascular age is this provided to the patient and may be older than the patient's actual age (indicating poor cardiovascular health), the same as the patient's actual age (indicating average cardiovascular health), or younger than the patient's actual age (indicating ideal cardiovascular health). Optionally health information may also be provided based on the personal risk factors, CVH score, vascular age, or comparisons to previous values or predetermined thresholds.
    Type: Application
    Filed: March 21, 2019
    Publication date: September 26, 2019
    Inventors: Vanessa Xanthakis, Danielle Enserro, Vasan Ramachandran, Robyn McClelland, Bridget Kruszka, Ralph Sacco, Chuanhui Dong, Adolfo Correa, Eduardo Sanchez
  • Publication number: 20180306797
    Abstract: Among the various aspects of the present disclosure is the provision of a method of detecting ceramides as prognostic indicators. An aspect of the present disclosure provides for a prognostic indicator for risk of developing a cardiovascular-related disease, disorder, or condition and mortality risk.
    Type: Application
    Filed: April 24, 2018
    Publication date: October 25, 2018
    Inventors: Jean E. Schaffer, Daniel S. Ory, Linda R. Peterson, Xuntian Jiang, Vasan S. Ramachandran, Vanessa Xanthakis, Meredith S. Duncan